IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer - PubMed (original) (raw)

Review

doi: 10.1038/nrc2889.

Affiliations

• PMID: 20651737
• DOI: 10.1038/nrc2889

Review

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

Mads Gyrd-Hansen et al. Nat Rev Cancer. 2010 Aug.

Abstract

The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are associated with chemoresistance, disease progression and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacological inhibitors of IAPs. The development of such inhibitors has radically changed our knowledge of the signalling processes that are regulated by IAPs. Recent studies indicate that IAPs not only regulate caspases and apoptosis, but also modulate inflammatory signalling and immunity, mitogenic kinase signalling, proliferation and mitosis, as well as cell invasion and metastasis.

PubMed Disclaimer

Similar articles

• Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation.
  Silke J, Meier P. Silke J, et al. Cold Spring Harb Perspect Biol. 2013 Feb 1;5(2):a008730. doi: 10.1101/cshperspect.a008730. Cold Spring Harb Perspect Biol. 2013. PMID: 23378585 Free PMC article. Review.
• The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
  LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. LaCasse EC, et al. Oncogene. 1998 Dec 24;17(25):3247-59. doi: 10.1038/sj.onc.1202569. Oncogene. 1998. PMID: 9916987 Review.
• The inhibitors of apoptosis (IAPs) as cancer targets.
  Hunter AM, LaCasse EC, Korneluk RG. Hunter AM, et al. Apoptosis. 2007 Sep;12(9):1543-68. doi: 10.1007/s10495-007-0087-3. Apoptosis. 2007. PMID: 17573556 Review.
• [IAPs: a central element in the NF-κB activating signaling pathway].
  Cartier J, Marivin A, Berthelet J, Dubrez L. Cartier J, et al. Med Sci (Paris). 2012 Jan;28(1):69-75. doi: 10.1051/medsci/2012281019. Epub 2012 Jan 27. Med Sci (Paris). 2012. PMID: 22289833 Review. French.
• IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.
  Gyrd-Hansen M, Darding M, Miasari M, Santoro MM, Zender L, Xue W, Tenev T, da Fonseca PC, Zvelebil M, Bujnicki JM, Lowe S, Silke J, Meier P. Gyrd-Hansen M, et al. Nat Cell Biol. 2008 Nov;10(11):1309-17. doi: 10.1038/ncb1789. Epub 2008 Oct 19. Nat Cell Biol. 2008. PMID: 18931663 Free PMC article.

Cited by

• NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival.
  Calandria JM, Asatryan A, Balaszczuk V, Knott EJ, Jun BK, Mukherjee PK, Belayev L, Bazan NG. Calandria JM, et al. Cell Death Differ. 2015 Aug;22(8):1363-77. doi: 10.1038/cdd.2014.233. Epub 2015 Jan 30. Cell Death Differ. 2015. PMID: 25633199 Free PMC article.
• Anti-apoptotic signaling as a cytoprotective mechanism in mammalian hibernation.
  Rouble AN, Hefler J, Mamady H, Storey KB, Tessier SN. Rouble AN, et al. PeerJ. 2013 Feb 12;1:e29. doi: 10.7717/peerj.29. Print 2013. PeerJ. 2013. PMID: 23638364 Free PMC article.
• An apoptosis-independent role of SMAC in tumor suppression.
  Qiu W, Liu H, Sebastini A, Sun Q, Wang H, Zhang L, Yu J. Qiu W, et al. Oncogene. 2013 May 9;32(19):2380-9. doi: 10.1038/onc.2012.265. Epub 2012 Jul 2. Oncogene. 2013. PMID: 22751125 Free PMC article.
• Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.
  Sisson TH, Ajayi IO, Subbotina N, Dodi AE, Rodansky ES, Chibucos LN, Kim KK, Keshamouni VG, White ES, Zhou Y, Higgins PD, Larsen SD, Neubig RR, Horowitz JC. Sisson TH, et al. Am J Pathol. 2015 Apr;185(4):969-86. doi: 10.1016/j.ajpath.2014.12.005. Epub 2015 Feb 11. Am J Pathol. 2015. PMID: 25681733 Free PMC article.
• Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein.
  McKee CM, Ding Y, Zhou J, Li C, Huang L, Xin X, He J, Allen JE, El-Deiry WS, Cao Y, Muschel RJ, Xu D. McKee CM, et al. Oncotarget. 2015 Feb 28;6(6):3784-96. doi: 10.18632/oncotarget.2921. Oncotarget. 2015. PMID: 25686839 Free PMC article.

References

1. 1. J Biol Chem. 2008 Sep 5;283(36):24295-9 - PubMed
2. 1. Cancer Sci. 2009 Sep;100(9):1668-74 - PubMed
3. 1. Science. 1994 Apr 29;264(5159):677-83 - PubMed
4. 1. J Biol Chem. 2002 Dec 20;277(51):49644-50 - PubMed
5. 1. Cancer Res. 2010 Apr 1;70(7):2852-61 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program